CDKL2 and gastric cancer: In gastric cancer (Fang et al., 2018), loss of CDKL2 expression was significantly correlated with clinicopathological characteristics (such as pathologic staging, histologic type, and grade); moreover, it could shorten patient disease-free survival and OS.